Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Rifampicin and Febuxostat on Methotrexate PK
NCT05575297Phase 1Completed
- Sponsor
- Seoul National University Hospital
- Start
- Dec 2021
- Primary completion
- May 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of methotrexate (4 arms), sponsored by Seoul National University Hospital. Primary endpoints: Maximum Plasma Concentration of Methotrexate at 24 hours, Area Under the Curve to Last Measurable Concentration of Methotrexate at 24 hours and 1 more. Started Dec 2021; status: completed.
02
Drugs
methotrexate
Beyond the preview
Go deeper on NCT05575297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05575297.